Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 25013.91. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 58.58, a forward P/E of 41.71 and EPS of 2.91. At a stock price of 170.42 (-1.04%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 15.75% and more long-term 15.97% after five years. EPS growth quarter over quarter is 18.60%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 11.30%.
For performance, Illumina Inc. the past week has seen a gain of -1.92%. For the last month performance for Illumina Inc. is 2.45%. While the last quarter is 17.67% and half year, 6.84%. Finally for the year, performance is -15.51%.
The 52-week high for Illumina Inc., is at -20.09%, and for the 52-week low it comes to a value of 34.08%. The 20-day simple moving average is 9.90% and 7.93% for the 200-day simple moving average.
Volatility for the week is at 2.61%, and for the month it is 2.80%. Illumina Inc., has a target price of 154.25.
In terms of debt, long term debt/equity is 0.5, and for total debt/equity Illumina Inc. has 0.5. The gross margin is 70.00%, while operating margin is 24.60%, the profit margin is 18.70%. The current ratio is 3.7 and the quick ratio is 3.1.
Insider ownership is at 1.20%, with instituitional ownership at 97.70%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 146.78. The shares float is 145.1, with the float short at 4.20%, with short ratio coming to 5.09.
In terms of returns, the return on assets see Illumina Inc., get 11.40%, with its returns on investment at 16.60%. Return on equity is 22.10%. So will the investors see the target price of 154.25, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.